Updated:
VASO Corp
VASO Corp was incorporated in 1991 by Jing Song Zhang, executing a classic corporate inversion by first establishing a position in medical imaging equipment...
VASO Corp
VASO Corp was incorporated in 1991 by Jing Song Zhang, executing a classic corporate inversion by first establishing a position in medical imaging equipment before expanding into diversified finance. The firm's original device business — including its subsidiary VasoHealthcare — provides sales distribution for GE HealthCare imaging equipment to hospital networks, creating a proprietary origination pipeline for the equipment lease-financing book that now anchors the firm's strategy. The pivot into private credit occurred via Vaso Funding Corp, a wholly owned subsidiary that underwrites medical equipment loans and leases while also extending into commercial real estate bridge lending. Beyond healthcare finance, VASO participates in litigation finance, acquiring indirect interests in settled legal claims through structured purchases. The firm operates primarily in the United States, with its lending book concentrated in healthcare providers across the Northeast and Sun Belt regions. This three-legged structure — equipment distribution, lease finance, and legal-claim monetization — creates a closed loop where VASO's equipment sales force feeds its lending pipeline. The firm remains tightly held, with Zhang controlling a significant equity block. VASO Corp's subsidiary architecture includes VasoHealthcare for medical equipment distribution, Vaso Funding for its lending portfolio, and interests in legal-settlement receivables. In January 2024, the firm disclosed the full repayment of a senior secured note facility, materially strengthening its balance sheet flexibility heading into the refinancing cycle (per the firm, January 2024). The company is publicly listed on the OTC Markets, though trading volume is negligible, making it more of a public reporting vehicle than a typical small-cap equity. VASO Corp's structural differentiator is its dual identity: a healthcare distribution business that generates fee income while simultaneously functioning as a captive credit fund. The equipment sales force doesn't just earn commissions — it sources borrowers for the in-house finance arm, a model that would be difficult for a bank or standalone private credit fund to replicate without owning the distribution channel first.
General information
Firm type
Asset Manager
Year founded
1991
Location
Region
North America
Country
United States
City
Plainview
Corporate office
Plainview, NY, United States
Principals
Jing Song Zhang
Chief Executive Officer
Sector focus
Frequently asked questions
How does VASO Corp source its lending opportunities?
VASO originates medical equipment loans and leases through its VasoHealthcare subsidiary, which sells GE HealthCare imaging equipment to hospital networks. The distribution sales force effectively acts as a proprietary origination team, identifying healthcare providers that need financing for equipment purchases. This closed-loop model reduces external sourcing costs that independent commercial lenders typically incur.
What asset classes does VASO Corp participate in?
The firm operates across three primary asset classes: medical equipment lease financing, commercial real estate bridge lending, and litigation finance through the acquisition of settled legal-claim receivables. Its healthcare finance book is the largest exposure, funded through a wholly owned subsidiary, Vaso Funding Corp.
Is VASO Corp a public company or a private family office?
VASO Corp is a publicly listed company trading on the OTC Markets, but it functions closer to a closely held holding company. CEO Jing Song Zhang controls a substantial equity stake, and the stock's negligible trading volume means the firm operates without significant public-market scrutiny, similar to a family office or private investment vehicle.
How does the equipment distribution business connect to the lending strategy?
VasoHealthcare distributes GE HealthCare medical imaging equipment to US hospitals, generating commission income. Those hospital relationships then feed Vaso Funding Corp's equipment-lease underwriting pipeline, meaning the same sales force that earns distribution fees also sources credit opportunities — a structural integration rare among standalone specialty-finance companies.
Who controls investment decisions at VASO Corp?
CEO Jing Song Zhang serves as the primary decision-maker across both the healthcare distribution and specialty-finance arms. The firm's small-scale, founder-led structure concentrates credit-approval and capital-allocation authority with Zhang, who has overseen the pivot from pure medical-device sales into diversified lending over more than three decades.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: